VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: “COOL”), (OTCQB: “CLABF”), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) a life sciences biotechnology research and development company focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of novel delivery systems technology is pleased to announce that it has received approval to upgrade from the OTC Pink Market to the OTCQB® Venture Market (the “OTCQB“).